Literature DB >> 7261923

[Clinical laboratory diagnosis of urolithiasis].

D Scholz, P O Schwille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7261923     DOI： 10.1055/s-2008-1070442

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  6 in total

1.  Parathyroid gland function in subgroups of metabolically mediated urolithiasis as evaluated by serum parathyroid hormone, and urinary and nephrogenous cyclic nucleotides.

Authors:  P O Schwille; D Scholz; K Schwille; W Engelhardt; B Schreiber; I Goldberg; A Sigel
Journal:  Klin Wochenschr       Date:  1982-03-01

2.  Fasting gastrinemia and elevated supersaturation with hydroxyapatite of fasting urine--observations in renal calcium stone patients and controls.

Authors:  P O Schwille; G Rümenapf; R Köhler; J H Weippert
Journal:  Urol Res       Date:  1987

3.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

4.  Crystalluria in idiopathic recurrent calcium urolithiasis. Dependence on stone composition.

Authors:  U Herrmann; P O Schwille
Journal:  Urol Res       Date:  1992

5.  Crystalluria determined by polarization microscopy. Technique and results in healthy control subjects and patients with idiopathic recurrent calcium urolithiasis classified in accordance with calciuria.

Authors:  U Herrmann; P O Schwille; P Kuch
Journal:  Urol Res       Date:  1991

6.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.

Authors:  U Herrmann; P O Schwille; H Schwarzlaender; I Berger; G Hoffmann
Journal:  Urol Res       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.